Intelligence · Clinical Development
Pipeline search results
Programs matching “covid-19” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 147 pipeline programs matching "covid-19" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
RO7496998
Atea Pharmaceuticals
COVID-19
1 trial -
Recombinant SARS-CoV-2 fusion protein vaccine (V-01)
Livzon Pharmaceutical Group
COVID-19 Pandemic
1 trial -
Recommended treatment schedule
Prime Medicine
COVID-19
1 trial -
SARS-CoV-2 Vaccine (Vero Cell), Inactivated
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
1 trial -
SARS-CoV-2 mRNA Vaccine
Biotech Pharmaceutical Co.,
COVID-19
1 trial -
SOC plus 15mg/kg EB05 IV
Edesa Biotech
COVID-19
1 trial -
Sarilumab
Regeneron UK Limited
COVID-19
1 trial -
TAK-019
Takeda
Coronavirus Disease (COVID-19)
1 trial -
Tice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine
United Therapeutics Europe Ltd
COVID-19
1 trial -
Traditional Chinese Medicine Prescription
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
VIR-7831
Vir Biotechnology
COVID-19
1 trial -
Yinhu Qingwen Granula
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
casirivimab+imdevimab combination therapy
Regeneron UK Limited
COVID-19
1 trial -
vitamin D
Takeda
COVID-19
1 trial -
ACT-20-MSC
Aspire Biopharma Holdings
COVID-19 Pneumonia
1 trial -
ARCT-165
Arcturus Therapeutics Holdings
COVID-19
1 trial -
AT-527
Atea Pharmaceuticals
COVID-19
2 trials -
Aprepitant injectable emulsion
Heron Therapeutics
COVID-19
1 trial -
BEVACIZUMAB
Pari Pharma GmbH
Adult patients with persistent dyspnea more than 3 months after acute COVID-19 infection.
1 trial -
Bamlanivimab
Vir Biotechnology
COVID-19
1 trial -
CERC-002
Avalo Therapeutics
COVID-19 Pneumonia
1 trial -
COVID-19 Vaccine HIPRA
Hipra Human Health S.L.
COVID-19
1 trial -
CYSTAGON 150 mg hard capsules
The George Institute
Infectious diseases of respiratory system (COVID-19)
1 trial -
Chinese Herb
Chinese University of Hong Kong
COVID-19
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.